Runben Biotechnology Co., Ltd. (SHA:603193)
China flag China · Delayed Price · Currency is CNY
34.87
+1.85 (5.60%)
Apr 24, 2025, 2:45 PM CST

Runben Biotechnology Revenue

Runben Biotechnology had revenue of 293.49M CNY in the quarter ending September 30, 2024, with 20.10% growth. This brings the company's revenue in the last twelve months to 1.25B, up 24.89% year-over-year. In the year 2023, Runben Biotechnology had annual revenue of 1.03B with 20.66% growth.

Revenue (ttm)
1.25B
Revenue Growth
+24.89%
P/S Ratio
11.32
Revenue / Employee
1.36M
Employees
917
Market Cap
14.11B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.03B176.87M20.66%
Dec 31, 2022856.09M273.94M47.06%
Dec 31, 2021582.15M139.32M31.46%
Dec 31, 2020442.83M164.19M58.93%
Dec 31, 2019278.64M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition